Two decades of declining cancer mortality: Progress with disparity

Annual Review of Public Health

Volumn 31, Issue , 2010, Pages 121-132

  Byers, Tim ^a  

^a Global Health and Health Disparities   (United States)

Author keywords

Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer; Trends

Indexed keywords

ALPHA TOCOPHEROL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTATE SPECIFIC ANTIGEN; RALOXIFENE; SELENIUM; TAMOXIFEN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COLORECTAL CANCER; EARLY DIAGNOSIS; ENDOSCOPY; HORMONE SUBSTITUTION; HUMAN; LUNG CANCER; MAMMOGRAPHY; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REVIEW; RISK REDUCTION; SMOKING CESSATION; SOCIAL CLASS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; RISK FACTORS; SOCIAL CLASS; UNITED STATES;

EID: 77952716850     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.121208.131047     Document Type: Review

References (34)

1. Am. Cancer Soc. Board Dir. 1996. ACS Challenge goals for U. S. cancer mortality for the year 2015. Proc. Board Dir. Atlanta, Georgia: Am. Cancer Soc.
2. Anderson R, Minino A, Hoyert D, Rosenberg H. 2001. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl. Vital Stat. Rep. 49(2):1-32
3. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, et al. 2009. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360(13):1310-1319
4. Berry D, Cronin K, Plevritis S, Fryback D, Clarke L, et al. 2005. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 353:1784-1792
5. Byers T, Barrera E, Fontham E, Newman L, Runowicz C, et al. 2006. A midpoint assessment of the American Cancer Society challenge goal to halve the U. S. cancer mortality rates between the years 1990 and 2015. Cancer 107:396-405
6. Byers T, Mouchawar J, Marks J, Cady B, Lins N, et al. 1999. The American Cancer Society challenge goals. How far can cancer rates decline in the U. S. by the year 2015? Cancer 86:715-727
7. Byers T, Wolf H, Bauer K, Bolick-Aldrich S, Chen VW, et al. 2008. The impact of socioeconomic status on cancer survival in the United States: findings from the Patterns of Care Study. Cancer 113:582-591
8. Cram P, Fendrick A, Inadomi J, Cowen M, Carpenter D, Vijan S. 2003. The impact of celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch. Intern. Med. 163(13):1601-1605
9. DeLancey J, Thun M, Jemal A, Ward E. 2008. Recent black-white disparities in cancer mortality. Cancer Epidemiol. Biomarkers Prev. 17:2908-2912
10. Duffy S, Smith R, Gabe R, Tabar L, Yen A, Chen T. 2005. Screening for breast cancer. Surg. Oncol. Clin. N. Am. 14:671-697
11. Giovino GA. 2002. Epidemiology of tobacco use in the United States. Oncogene 21:7326-7340
12. Gohagan J, Prorok P, Hayes R, Kramer B, PLCO Screening Trial Project Team. 2000. The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status. Control Clin. Trials 21(6 Suppl.):S251-72
13. Hersh A, Stefanick M, StaffordR. 2004. National useofpostmenopausal hormone therapy. JAMA 291:47-53
14. Int. Agency Cancer Res. 2002. Weight Control and Physical Activity. Handbook #6. Geneva, Switz.: IARC Press
15. Jemal A, Thun M, Ties L, Howe H, Weir H, et al. 2008. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J. Natl. Cancer Inst. 100:1672-1694
16. Kinsey T, Jemal A, Liff J, Ward E, Thun M. 2008. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J. Natl. Cancer Inst. 100:1003-1012
17. Kolata G. 2009. In long drive to cure cancer, advances have been elusive. New York Times, April 24: p. 1
18. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, et al. 2008. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5):1570-1595 (Pubitemid 351615355)
19. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, et al. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1):39-51
20. Marcus P, Bergstralh E, Zweig M, Harris A, Offord K, et al. 2006. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J. Natl. Cancer Inst. 98:748-756
21. Martinez M. 2005. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res. 166:177-211
22. Mokdad A, Bowman B, Ford E, Vinicor F, Marks J, Koplan J. 2001. The continuing epidemic of obesity and diabetes in the United States. JAMA 286:1195-1200
23. Potosky A, Feuer E, Levin D. 2001. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol. Rev. 23(1):181-186
24. Ryerson AB, Miller J, Eheman CR, White MC. 2007. Use of mammograms among women aged ≥40 years\United States, 2000-2005. MMWR 56:49-51
25. Schrö der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, et al. 2009. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360(13):1320-1328
26. Thompson I, Goodman P, Tengen C, Lucia M, Miller G, et al. 2003. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349:215-224 (Pubitemid 36859473)
27. U. S. Dep. Health Hum. Serv., Cent. Dis. Control Prev. 2009. CDC WONDER. http://www. cdc. gov/nccdphp
28. U. S. Preventive Services Task Force. 2009. Screening for breast cancer: U. S. Preventive Services Task Force recommendations statement. Ann. Intern. Med. 151:716-726
29. U. S. Public Health Serv. 1990. Surgeon General's Report on Smoking and Health. DHHS Publ. No. (CDC)90-8416, Washington, DC
30. U. S. Public Health Serv., U. S. Dep. Health Educ. Welfare. 1967. The Health Consequences of Smoking. A Public Health Service Review: 1967. Publ. No. 1696. Washington, DC: Public Health Serv.
31. Vogel V, Constantino J, Wickerham D, Cronin W, Cecchini R, et al. 2006. Effects of tamoxifen vs raloxifene on the risks of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727-2741
32. Warner E, Mulshine J. 2004. Lung cancer screening with spiral CT: toward a working strategy. Oncology 18(5):564-587
33. World Cancer Res. Fund/Am. Inst. Cancer Prev. 2009. Policy and Action for Cancer Prevention. Food, Nutrition, and Physical Activity: A Global Perspective. Washington, DC: AICR
34. Writing Group for the Women's Health Initiative Investigation. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333